Market Overview

Benzinga's Volume Movers

Related ACHN
SMid-Cap Biotech: Barclays Downgrades Prothena, Upgrades Achillion
Benzinga's Top Upgrades, Downgrades For May 21, 2018
Related RDUS
What's In Store For Radius Health In Q1 Earnings?
Insider Buys Of The Week: Intercept Pharmaceuticals, Macy's And More
Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 56'5(c)(4) (GuruFocus)

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) surged 11.33% to $15.82. The volume of Achillion Pharmaceuticals shares traded 1040% higher than normal. Achillion Pharmaceuticals shares gained on positive ACH-3102 and ACH-3422 data.

Radius Health, Inc. (NASDAQ: RDUS) shares rose 14.43% to $36.65. The volume of Radius Health shares traded was 833% higher than normal. Radius Health reported positive Phase 3 top-line results for its investigational drug abaloparatide-sc in postmenopausal women with severe osteoporosis.

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) shares moved up 9.42% to $51.01. The volume of Enanta Pharmaceuticals traded was 365% higher than normal. Enanta Pharmaceuticals announced that the FDA has approved AbbVie's (NYSE: ABBV) Viekira Pak.

Caesars Acquisition Company (NASDAQ: CACQ) shares climbed 8.46% to $10.26. The volume of Caesars Acquisition shares traded was 277% higher than normal. Caesars Entertainment Corporation (NASDAQ: CZR) and Caesars Acquisition Company announced that they will merge in an all-stock transaction.

Posted-In: volume moversNews Intraday Update Markets Movers


Related Articles (ACHN + ABBV)

View Comments and Join the Discussion!